John C.k. Milligan IV, President/Secretary at TherapeuticsMD, Inc. (TXMD), sold 258,000 shares at $4.99 ($1.3M) on 2018-11-15, disclosed to the SEC on 2018-11-16.
Open-market sale of $1.3M TXMD by President/Secretary. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.82 | 129,000 | $622K | 49.1% |
| 2 | $4.99 | 129,000 | $644K | 50.9% |
| Total | $4.91 avg | 258,000 | $1.3M | 100% |
| Filing → |
| TXMD | BUY | 2019-08-19 | $29K | — | Filing → |
| TXMD | BUY | 2019-08-14 | $47K | — | Filing → |
| TXMD | SELL | 2018-12-19 | $1.4M | — | Filing → |